Back to Browse Journals » Medical Devices: Evidence and Research » Volume 6

Cost-effective therapeutic hypothermia treatment device for hypoxic ischemic encephalopathy

Authors Kim JJ, Buchbinder N, Ammanuel S, Kim R, Moore E, O'Donnell N, Lee JK, Kulikowicz E, Acharya S, Allen RH, Lee RW, Johnston MV

Published Date January 2013 Volume 2013:6 Pages 1—10


Received 16 October 2012, Accepted 17 November 2012, Published 3 January 2013

John J Kim,1,2 Nathan Buchbinder,1,† Simon Ammanuel,1,4,5,† Robert Kim,1,† Erika Moore,1 Neil O'Donnell,1 Jennifer K Lee,3 Ewa Kulikowicz,3 Soumyadipta Acharya,1 Robert H Allen,1,9 Ryan W Lee,6,7 Michael V Johnston4–8

Department of Biomedical Engineering, Whiting School of Engineering, The Johns Hopkins University, 2The James Buchanan Brady Urological Institute, Department of Urology, The Johns Hopkins University School of Medicine, 3Department of Anesthesia and Critical Care Medicine, Johns Hopkins University, 4Kennedy Krieger Institute, 5Hugo W Moser Research Institute, 6Department of Neurology, 7Department of Pediatrics, 8Department of Physical Medicine and Rehabilitation Johns Hopkins University School of Medicine, Baltimore, MD; 9Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA

These authors contributed equally to this work

Abstract: Despite recent advances in neonatal care and monitoring, asphyxia globally accounts for 23% of the 4 million annual deaths of newborns, and leads to hypoxic-ischemic encephalopathy (HIE). Occurring in five of 1000 live-born infants globally and even more in developing countries, HIE is a serious problem that causes death in 25%–50% of affected neonates and neurological disability to at least 25% of survivors. In order to prevent the damage caused by HIE, our invention provides an effective whole-body cooling of the neonates by utilizing evaporation and an endothermic reaction. Our device is composed of basic electronics, clay pots, sand, and urea-based instant cold pack powder. A larger clay pot, lined with nearly 5 cm of sand, contains a smaller pot, where the neonate will be placed for therapeutic treatment. When the sand is mixed with instant cold pack urea powder and wetted with water, the device can extract heat from inside to outside and maintain the inner pot at 17°C for more than 24 hours with monitoring by LED lights and thermistors. Using a piglet model, we confirmed that our device fits the specific parameters of therapeutic hypothermia, lowering the body temperature to 33.5°C with a 1°C margin of error. After the therapeutic hypothermia treatment, warming is regulated by adjusting the amount of water added and the location of baby inside the device. Our invention uniquely limits the amount of electricity required to power and operate the device compared with current expensive and high-tech devices available in the United States. Our device costs a maximum of 40 dollars and is simple enough to be used in neonatal intensive care units in developing countries.

Keywords: therapeutic hypothermia, evaporative cooling, hypoxic ischemic encephalopathy, birth asphyxia, neuroprotection

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Readers of this article also read:

The KineSpring® Knee Implant System: an implantable joint-unloading prosthesis for treatment of medial knee osteoarthritis

Clifford AG, Gabriel SM, O’ Connell M, Lowe D, Miller LE, Block JE

Medical Devices: Evidence and Research 2013, 6:69-76

Published Date: 17 May 2013

Novel anterior cruciate ligament graft fixation device reduces slippage

Lopez MJ, Borne A, Monroe WT, Bommala P, Kelly L, Zhang N

Medical Devices: Evidence and Research 2013, 6:59-68

Published Date: 14 May 2013

Limitations of using synthetic blood clots for measuring in vitro clot capture efficiency of inferior vena cava filters

Robinson RA, Herbertson LH, Sarkar Das S, Malinauskas RA, Pritchard WF, Grossman LW

Medical Devices: Evidence and Research 2013, 6:49-57

Published Date: 10 May 2013

Bioresorbable scaffolds in the treatment of coronary artery disease

Zhang Y, Bourantas CV, Farooq V, Muramatsu T, Diletti R, Onuma Y, Garcia-Garcia HM, Serruys PW

Medical Devices: Evidence and Research 2013, 6:37-48

Published Date: 12 March 2013

A patient-level meta-analysis of studies evaluating vagus nerve stimulation therapy for treatment-resistant depression

Berry SM, Broglio K, Bunker M, Jayewardene A, Olin B, Rush AJ

Medical Devices: Evidence and Research 2013, 6:17-35

Published Date: 1 March 2013

Congenital malformations in Ecuadorian children: urgent need to create a National Registry of Birth Defects

Fabricio González-Andrade, Ramiro López-Pulles

The Application of Clinical Genetics 2010, 3:29-39

Published Date: 14 April 2010

Alogliptin: a new addition to the class of DPP-4 inhibitors

Radha Andukuri, Andjela Drincic, Marc Rendell

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:117-126

Published Date: 21 July 2009